CNBC December 17, 2024
Ashley Capoot

Key Points

– Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose.

– The company has been building a generative AI platform with technology from Google Cloud.

– The report breaks down how Stelo users’ meals, sleep and activity impact their glucose levels, and it includes relevant tips and educational materials.

Dexcom on Tuesday announced an artificial intelligence feature for its Stelo continuous glucose monitor that gives users a personalized look into how meals, sleep and activity impact their glucose levels. It’s the first iteration of a new generative AI platform that the company has been building with Google Cloud.

Stelo is an over-the-counter...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Digital Health, Patient / Consumer, Provider, Technology, Wearables
New technique helps LLMs rein in CoT lengths, optimizing reasoning without exploding compute costs
Generative AI and deepfakes are fueling health misinformation. Here's what to look out for so you don't get scammed
Using machine learning tools to detect gene mutations from leukemia cell images
Beyond Documentation: Building Platform Moats in Healthcare AI
OpenAI calls for US to centralize AI regulation

Share This Article